Articles in Drug and Therapeutics Bulletin (DTB) aim to provide practical and impartial advice on treatment. Since it started in 1962, the way that DTB produces articles has been gradually refined but the essential principles remain unchanged. While each article starts as a draft commissioned by one of our editorial team and written by an expert, the finished article is the result of detailed scrutiny, collaboration and revision involving a wide range of commentators and several editing stages. The resulting article, no longer attributable to any one source, is published unsigned. Here we describe our approach to producing articles and discuss some of the difficulties they pose.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.